Susan Hasty, Publisher
Table of Contents . . . January 21st, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Bioterrorism Week | Other Publications
Anthrax - Clarithromycin Active In Vitro With Low Resistance
Biological Warfare - Company Outlines Strategies for Bioweapons Defense
Bioterrorism - Dubious Protection Products Being Sold On Internet
Emergency Medicine - Immediate Local Action Needed to Prepare for Mass Casualty Incidents
Anthrax - Topical Antimicrobial Formula Tests Highly Effective Against Spore Bacteria
Biological Warfare - North Shore-LIJ Awarded Defense Contract Worth $1.6 Million
Biological Warfare - Portable Endospore Detection System Offers Real-Time Anthrax Screening
Bioterrorism - DNA Analyses Help Identify World Trade Towers Victims
Bioterrorism - Los Alamos Lab Considers New Policy On Virulent Anthrax
Diagnostics - Cepheid Delivers GeneXpert to U.S. Army
Immunization - South Korean Military To Buy Anthrax Vaccines
Obstetrics - ACOG Addresses Controversies, Releases Guidelines
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.